Parenterals and injectables are the fastest growing dosage forms within the pharmaceutical industry, partially as a result of the uptick in orphan therapies, precision medicines, and biopharmaceutical drug products. Active pharmaceutical ingredients (APIs) are increasingly difficult to therapeutically deliver due to bioavailability issues and water insolubility, which often necessitates their administration as an injection.
